Samuel Blackman is the founder of Day One Biopharmaceuticals. Day One Biopharmaceuticals has raised $1M in total funding. Latest round: Seed.
Samuel Blackman is the co-founder of Day One Biopharmaceuticals, where he initially served as Head of Research & Development. He founded the company in November 2018 with approximately $1 million in seed capital. Blackman is recognized as an oncology R&D expert and joined the board of directors at Pheon Therapeutics after his retirement from Day One.
Full founder directory · Investor directory · Company funding database · Fundraising library